Big Data in Capital Markets: The Placebo Effect?
Report Summary
Big Data in Capital Markets: The Placebo Effect?
Big data—jargon, or strategy?
London, 8 October 2014 – The capital markets have been relatively slow to adopt big-data strategies, but these strategies are beginning to appear in a select few areas, including sentiment analysis for trading, risk analytics, and market surveillance. Uncertainty remains about what big data actually is, however: A technology? A strategy? A placebo term for all projects that tackle data? And finally, is it actually making an impact in this space?
Based on Aite Group interviews with 22 buy-side and sell-side firms that have knowledge of big-data strategies and technologies, this piece identifies challenges and opportunities in big-data initiatives and analyzes the potential benefits of adopting big-data strategies and technologies within the capital markets community.
This 41-page Impact Report contains 29 figures. Clients of Aite Group's Institutional Securities & Investments service can download this report.